Patent details

EN | LT

LT - USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS

EN - USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 31/444
		A61K 31/4709
		A61K 45/06
		A61P 35/00

European patent
(11)	Number of the document	2182948
(13)	Kind of document	T
(96)	European patent application number	08786340.3
	Date of filing the European patent application	2008-07-23
(97)	Date of publication of the European application	2010-05-12
(45)	Date of publication and mention of the grant of the patent	2013-03-06
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2008/059642
	Date	2008-07-23

PCT application publication
(87)	Number	WO 2009/013305
	Date	2009-01-29

Priority applications
(30)	Number	Date	Country code
	07112998	2007-07-24	EP

Inventors
(72)	GARCIA-ECHEVERRIA, Carlos, CH MAIRA, Sauveur-Michel, FR

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Title
(54)	USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS
	USE OF IMIDAZOQUINOLINES FOR THE TREATMENT OF EGFR DEPENDENT DISEASES OR DISEASES THAT HAVE ACQUIRED RESISTANCE TO AGENTS THAT TARGET EGFR FAMILY MEMBERS